The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...
Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.
Abbott has initiated a voluntary medical device correction for a number of FreeStyle Libre 3 sensors distributed in the United States during the first half of May 2024. The FreeStyle Libre 3 system ...
A newly issued alert links certain FreeStyle Libre 3 and 3 Plus glucose-monitoring sensors to at least seven deaths and hundreds of serious injuries. The problem stems from sensors giving falsely low ...
A subset of FreeStyle Libre 3 and Libre 3 Plus sensors can give falsely low glucose readings Only specific Libre 3 and Libre 3 Plus sensors are affected. Abbott, the manufacturer of FreeStyle Libre, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results